Therefore, renalase deficiency suppresses lipid metabolism via the Akt–Srebf1 pathway and suggests a potential role in attenuating the hepatic lipid accumulation that precedes MASLD pathogenesis. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.